Chelsea J Guy-Frank1, Kishore Persaud2, Dmitry Butsenko3, Rahul M Jindal4, Stephen R Guy5. 1. Department of General Surgery, UT Southwestern, Dallas, TX, USA. 2. Transplant Program, Guyana Public Health Corporation, Georgetown, Guyana. 3. State University of New York Upstate Medical University, Syracuse, NY, USA. 4. USU-Walter Reed Department of Surgery, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA. jindalr@msn.com. 5. Abdominal Transplant, Drexel University College of Medicine, Philadelphia, PA, USA.
Abstract
INTRODUCTION: The initiation of a kidney transplant program, in a low- and middle-income country, while striving to maintain excellent outcomes and adhere to high ethical, legal standards, is a formidable task. Herein, we review the outcomes and challenges of a living donor kidney transplant program from its inception to sustainability, in Guyana, South America. METHODS: This is a retrospective review of a living donor kidney transplant program instituted in Guyana in 2008. Data included recipient and donor demographics, cause of renal failure, donor-recipient matching and relationship, perioperative complications, timing and cause of death, graft failure, surgical technique, and laterality of organ procured. Patient and donor data were compared by phases and additionally compared to United States Renal Data Base System. Survival outcomes were compared by phases and by Kaplan-Meier curves. RESULTS: To date, 45 kidney transplants have been completed. Phase I (2007-2008) was the initiation of the program, which was comprised of upgrading hospital and operating rooms, obtaining antirejection medications, educating local providers, fostering a relationship with the government, and screening patients and living donors. We also began vascular access and peritoneal dialysis in the country, as well as introduced the companion public health service initiative: the SEVAK program. Phase II (2008-2014) involved completion of 25 living donor kidney transplants, of which there have been 11 confirmed deaths and 10 lost to follow-up. In Phase III (2015-present), 20 transplants have been completed to date, of whom only 1 died and none were lost to follow-up. In the third phase, we also introduced corneal transplantation to Guyana and have performed over 100 transplants. CONCLUSION: Kidney transplantation can be safely and ethically performed in a low- and middle-income country. We applied lessons learnt from the first two phases to improve follow-up by appointing a local coordinator who goes to patient's homes in remote villages. Currently, there is a stable local team that is performing transplants and following the patients. We believe that our model of public-private partnership can sustain kidney, as well as corneal, transplantation and could be replicated in other countries.
INTRODUCTION: The initiation of a kidney transplant program, in a low- and middle-income country, while striving to maintain excellent outcomes and adhere to high ethical, legal standards, is a formidable task. Herein, we review the outcomes and challenges of a living donor kidney transplant program from its inception to sustainability, in Guyana, South America. METHODS: This is a retrospective review of a living donor kidney transplant program instituted in Guyana in 2008. Data included recipient and donor demographics, cause of renal failure, donor-recipient matching and relationship, perioperative complications, timing and cause of death, graft failure, surgical technique, and laterality of organ procured. Patient and donor data were compared by phases and additionally compared to United States Renal Data Base System. Survival outcomes were compared by phases and by Kaplan-Meier curves. RESULTS: To date, 45 kidney transplants have been completed. Phase I (2007-2008) was the initiation of the program, which was comprised of upgrading hospital and operating rooms, obtaining antirejection medications, educating local providers, fostering a relationship with the government, and screening patients and living donors. We also began vascular access and peritoneal dialysis in the country, as well as introduced the companion public health service initiative: the SEVAK program. Phase II (2008-2014) involved completion of 25 living donor kidney transplants, of which there have been 11 confirmed deaths and 10 lost to follow-up. In Phase III (2015-present), 20 transplants have been completed to date, of whom only 1 died and none were lost to follow-up. In the third phase, we also introduced corneal transplantation to Guyana and have performed over 100 transplants. CONCLUSION: Kidney transplantation can be safely and ethically performed in a low- and middle-income country. We applied lessons learnt from the first two phases to improve follow-up by appointing a local coordinator who goes to patient's homes in remote villages. Currently, there is a stable local team that is performing transplants and following the patients. We believe that our model of public-private partnership can sustain kidney, as well as corneal, transplantation and could be replicated in other countries.
Authors: Maria Altieri; Tarun R Jindal; Mayur Patel; David K Oliver; Edward M Falta; Eric A Elster; Alden Doyle; Stephen R Guy; Arthur L Womble; Rahul M Jindal Journal: Perit Dial Int Date: 2013 Mar-Apr Impact factor: 1.756
Authors: Mohammed A Kaballo; Mark Canney; Patrick O'Kelly; Yvonne Williams; Conall M O'Seaghdha; Peter J Conlon Journal: Clin Kidney J Date: 2017-10-18
Authors: Dominic Mudiayi; Soroush Shojai; Ikechi Okpechi; Emily A Christie; Kevin Wen; Mostafa Kamaleldin; Mohamed Elsadig Osman; Meaghan Lunney; Bhanu Prasad; Mohamed A Osman; Feng Ye; Maryam Khan; Htay Htay; Fergus Caskey; Kailash K Jindal; Scott Klarenback; Vivekanand Jha; Eric Rondeau; Rumeyza Turan Kazancioglu; Shahrzad Ossareh; Kitty J Jager; Csaba P Kovesdy; Philip J O'Connell; Elmi Muller; Timothy Olanrewaju; John S Gill; Marcello Tonelli; David C Harris; Adeera Levin; David W Johnson; Aminu K Bello Journal: Transplantation Date: 2022-09-07 Impact factor: 5.385
Authors: Melissa Adomako; Alaei Kamiar; Abdulla Alshaikh; Lyndsay S Baines; Desiree Benson; Douglas W Bettcher; Baljit Cheema; Lex Corijn; Evan Fountain; Bartosz G Gdaniec; Elan Garonzik; Mary Harney; Rahul M Jindal; Kate Jones; David Kerr; Deena Mehjabeen; Nick P Vahid; Emem Okonetuk; Nathalia Pompeu; Bongekile Skosana; Soo Tan; Karabo Thokwane; Tyson Welzel Journal: Int Health Date: 2020-05-01 Impact factor: 2.473